Azadeh Golipour - 08 Jun 2022 Form 3 Insider Report for AVROBIO, Inc. (TECX)

Role
Chief Technology Officer
Signature
/s/ Christopher Gerry, Attorney in Fact for Azadeh Golipour
Issuer symbol
TECX
Transactions as of
08 Jun 2022
Net transactions value
$0
Form type
3
Filing time
17 Jun 2022, 16:34:33 UTC
Next filing
09 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AVRO Common Stock 36,344 08 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AVRO Stock Option (Right to Buy) 08 Jun 2022 Common Stock 353 $1.20 Direct F2
holding AVRO Stock Option (Right to Buy) 08 Jun 2022 Common Stock 736 $0.9100 Direct F2
holding AVRO Stock Option (Right to Buy) 08 Jun 2022 Common Stock 5,908 $5.00 Direct F2
holding AVRO Stock Option (Right to Buy) 08 Jun 2022 Common Stock 20,000 $16.98 Direct F3
holding AVRO Stock Option (Right to Buy) 08 Jun 2022 Common Stock 31,500 $20.98 Direct F4
holding AVRO Stock Option (Right to Buy) 08 Jun 2022 Common Stock 25,000 $14.57 Direct F5
holding AVRO Stock Option (Right to Buy) 08 Jun 2022 Common Stock 46,000 $16.02 Direct F6
holding AVRO Stock Option (Right to Buy) 08 Jun 2022 Common Stock 100,000 $1.84 Direct F7
holding AVRO Stock Option (Right to Buy) 08 Jun 2022 Common Stock 130,000 $1.84 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 36,344 RSUs granted on June 10, 2021. 50% of the shares vest on the second anniversary of the grant date and the remaining 50% vest on the third anniversary of the grant date.
F2 Fully vested.
F3 25% of the shares vested on February 25, 2020, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.
F4 25% of the shares vested on March 2, 2021, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.
F5 25% of the shares vested on January 4, 2022, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.
F6 25% of the shares vested on February 4, 2022, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.
F7 25% of the shares vest on February 2, 2023, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.

Remarks:

Exhibit 24 - Power of Attorney